Huang Yiming, Kucia Magda, Rezzoug Francine, Ratajczak Janina, Tanner Michael K, Ratajczak Mariusz Z, Schanie Carrie L, Xu Hong, Fugier-Vivier Isabelle, Ildstad Suzanne T
Institute for Cellular Therapeutics, University of Louisville, 570 S. Preston Street, Suite 404, Louisville, Kentucky 40202-1760, USA.
Stem Cells. 2006 Apr;24(4):936-48. doi: 10.1634/stemcells.2005-0395.
Facilitating cells (CD8+/TCR-) (FCs) enhance engraftment of limiting numbers of hematopoietic stem cells (HSCs). The primary component of FCs is precursor-plasmacytoid dendritic cells (p-preDCs), a tolerogenic cell expanded by Flt3-ligand (FL). In this study, we evaluated the function and composition of FL-expanded FCs. FL treatment resulted in a significant increase of FCs in bone marrow (BM) and peripheral blood (PB). When FL-expanded FCs were transplanted with c-Kit+/Sca-1+/Lin- (KSL) cells into allogeneic recipients, BM-FCs exhibited significantly impaired function whereas PB-FCs were potently functional. A significant upregulation of P-selectin expression and downregulation of VCAM-1 (vascular cell adhesion molecule 1) were present on FL-expanded PB-FCs compared with FL BM-FCs. Stromal cell-derived factor-1 (SDF-1), and CXCR4 transcripts were significantly increased in FL PB-FCs and decreased in FL BM-FCs. Supernatant from FL PB-FCs primed HSC migration to SDF-1, confirming production of the protein product. The FL PB-FCs contained a predominance of p-preDCs and natural killer (NK)-FCs, and NK-FCs were lacking in FL BM-FCs. The impaired function for BM-FCs was restored within 5 days after cessation of treatment. Taken together, these data suggest that FCs may enhance HSC homing and migration via the SDF-1/CXCR4 axis and adhesion molecule modulation. These findings may have implications in development of strategies for retaining function of ex vivo manipulated FCs and HSCs.
辅助细胞(CD8⁺/TCR⁻)(FCs)可增强有限数量造血干细胞(HSCs)的植入。FCs的主要成分是前体浆细胞样树突状细胞(p-preDCs),这是一种由Flt3配体(FL)扩增的耐受性细胞。在本研究中,我们评估了FL扩增的FCs的功能和组成。FL处理导致骨髓(BM)和外周血(PB)中FCs显著增加。当将FL扩增的FCs与c-Kit⁺/Sca-1⁺/Lin⁻(KSL)细胞一起移植到异基因受体中时,BM-FCs的功能显著受损,而PB-FCs功能强大。与FL BM-FCs相比,FL扩增的PB-FCs上P-选择素表达显著上调,血管细胞黏附分子1(VCAM-1)表达下调。基质细胞衍生因子-1(SDF-1)和CXCR4转录本在FL PB-FCs中显著增加,在FL BM-FCs中减少。FL PB-FCs的上清液可诱导HSC向SDF-1迁移,证实了该蛋白产物的产生。FL PB-FCs主要包含p-preDCs和自然杀伤(NK)-FCs,而FL BM-FCs中缺乏NK-FCs。停止治疗后5天内,BM-FCs受损的功能得以恢复。综上所述,这些数据表明FCs可能通过SDF-1/CXCR4轴和黏附分子调节增强HSC归巢和迁移。这些发现可能对制定保留体外操作的FCs和HSCs功能的策略具有启示意义。